Maggot debridement therapy is a safe and very effective method for treating poorly healing wounds.

Here is an example of an ulcer on the ankle of a 59 year old man.  He came into my practice after consulting many other doctors who had prescribed antibiotics or who diagnosed it as a venous stasis ulcer.

The patient first developed a wound on the medial malleolus of his right ankle when he was a young child riding in the basket of a bicycle. The medial malleolus is the protruding part on the inside of the ankle which is part of the tibial bone. The spokes of the bicycle wheel broke as his foot was trapped so the injury was severe. Eventually, this wound healed with a silver colored scar and did not bother him for about 30 years.

However, when he was in his early forties he hit his ankle with a piece of wood and developed another wound. It was not at the same location as his childhood injury but it was more proximal (3-4 inches towards the knee). Various antibiotic treatments were unsuccessful. After one antibiotic treatment he developed persistent diarrhea for one year so he was reluctant to take antibiotics again.

He had been struggling with this painful wound for almost 20 years when an acupuncturist recommended maggot debridement therapy. His next challenge was to find a physician willing to offer this. Fortunately, he was able to find me through the Monarch Labs website.

This is what his wound looked like during the first visit before receiving maggot debridement therapy.

Nonviable, necrotic (dead) tissue is visible in the wound.

Nonviable, necrotic (dead) tissue is visible in the wound.

In the following picture you can see the maggots. They are only a few millimeters in length. As they feast on the dead tissue they are able increase in size rapidly. It is not unusual for them to become four to five times bigger in one day.

First application of maggots

First application of maggots

Two days later the wound looked much cleaner. The maggots had removed the necrotic tissue. This makes it possible for the wound to heal and close. Interestingly, the maggots were no longer in the wound when we removed the dressing. The patient was sure that they had not escaped so the likely explanation is that the maggots ran out of dead tissue to feast on and died.

The wound looks much better. The maggots have removed the necrotic tissue.

The wound looks much better. The maggots have removed the necrotic tissue.

This is the second application of maggots.

Second application of maggots

Second application of maggots

This a short video of the maggots moving around in the wound.

This is what the wound dressing looks like. It is secured with tape on all sides to make sure that maggots don’t escape from their “cage”. The center of the dressing allows the maggots to breathe.

The maggots and the wound are now covered by a hydrocolloid wound dressing.

The maggots and the wound are now covered by a hydrocolloid wound dressing.

The following pictures are from Day 3, four days after the first application of maggots. The wound looks clean. The maggots have greatly increased in size.

Grown maggots are visible after removal of the dressing.

Grown maggots are visible after removal of the dressing.

Third application of maggots.

Third application of maggots.

Third application of maggots.

After the fourth application the wound is shallower. The diameter of the wound has not yet changed significantly. The area around the wound is less tender.

After the fourth application the wound is shallower.

Here are resources on maggot debridement therapy:

Advertisements

What else is new from the FDA? Click here to read the complete article.

Why isn’t the FDA doing anything to address those “Food Supplements”/additives such as MSG (monosodium glutamate), hormone disruptors, pesticides, antibiotics, genetically modified organisms, and high fructose corn syrup that are really a threat to the American public?

FOR IMMEDIATE RELEASE
Orthomolecular Medicine News Service, October 9, 2008
FDA Claims “Food Supplement” Deaths; Hides Details from the Public

(OMNS, October 9, 2008) “Dietary supplements cause 600 ‘adverse events'”, reported USA Today on 22 Sept, 2008. In an article that looks much like an official US Food and Drug Administration press release, it said that “Serious side effects from the use of food supplements resulted in 604 “adverse-event” reports – a list that includes at least five deaths – through the first six months that such accounts have been required by law.” (1)

Good grief! Looks like all those supplement-popping health nuts really are nuts after all. Food supplements simply must be dangerous!

Or are they?

Later on in the article, far from the headline, USA Today conceded that “An adverse event can be anything from a concern that a supplement isn’t working to a serious illness that follows consumption.” And, FDA spokesman Michael Herndon admitted that of the five deaths and 85 hospitalizations reported, “Some of these deaths were likely due to underlying medical conditions.”

FDA’s method of gaining data is suspect at best and biased at worst. Their “Dietary Supplement Adverse Event Reporting” webpage, http://www.cfsan.fda.gov/~DMS/ds-rept.html, states: “FDA would like to know when a product causes a problem even if you are unsure the product caused the problem or even if you do not visit a doctor or clinic.” The measure of uncertainty involved in publicly soliciting adverse reports “even if you are unsure that the product caused the problem” is noteworthy.

Click here to read the complete article.

Here are some resources for patients who are suffering from cancer:

Books from Hulda Regehr Clark, Ph.D., N.D. www.drclark.net
The Prevention of All Cancers
The Cure for All Cancers

Beating Cancer with Nutrition by Patrick Quillin, Ph.D. R.D., C.N.S.
www.NutritionCancer.com

The Gerson Therapy – The Proven Nutritional Program for Cancer and Other Illnesses by Charlotte Gerson and Morton Walker, D.P.M.
www.gerson.org

NeuroModulation Techniquewww.nmt.md
NeuroModulation Technique can be a beneficial adjunctive modality for patients with cancer because it can enhance immune system functioning.

The Cancer Cure Foundationwww.cancure.org
– Information on Mexican Clinics:
http://www.cancure.org/directory_mexican_clinics.htm

Alternative-Cancer.net
www.alternative-cancer.net
– Information about Mexican Hospitals:
http://www.alternative-cancer.net/mexican_hospitals.htm

NaturalNews.comwww.naturalnews.com
– The media assault on Mexico’s alternative cancer clinics:
http://www.naturalnews.com/017410.html

Cancer Clinics in Mexico:
Hope4Cancer Institute – www.hope4cancer.com
Instituto de Investigaciones Biomedicas – www.iibmed.com
Oasis Hospital – www.oasisofhope.com

Please post a comment if you have any experience with any of these resources or if you know of any others that may be helpful for patients with cancer.

After having been referred to me by a colleague, a woman who was interested in bioidentical hormone therapy contacted me. She told me that she had suffered a stroke while taking FemHRT. She thought that FemHRT was a form of bioidentical hormone therapy and she asked me if the hormone therapy that I offer to my patients could put her at risk of developing another stroke.

This is a concern that many women have. In the mainstream media estrogen is depicted as a hormone that causes cancer and other health problems. It is this misinformation that causes many women to shy away from seeking treatment for hormone deficiencies or imbalances.

FemHRT DOES NOT contain bioidentical hormones. It consists of norethindrone acetate and ethinyl estradiol.

What is the difference between bioidentical hormones and nonbioidentical hormones?

Bioidentical hormones are messenger chemicals that are identical to hormones that the human body makes in its hormone glands. There is no difference. They are identical in every way. They are made from ingredients of wild yams or soy beans. So they are synthetic hormones but bioidentical. Examples of bioidentical hormones are estradiol, estriol, estrone, testosterone, progesterone, pregnenolone, dehydroepiandrosterone (DHEA), growth hormone, triiodothyronine (T3), thyroxine (T4), hydrocortisone, and aldosterone. The body’s hormone glands make all of these and more and compounding pharmacies are able to make them available for therapeutic applications.

“Nonbioidentical hormones” are not produced by the human body and as such they are considered foreign to the body. Examples are norethindrone, ethinyl estradiol, hormones from other species (e.g., Premarin which contains estrogens derived from horse urine), all oral contraceptives, and most injectable hormones. It would be better to refer to these chemicals as hormone disruptors because they are not hormones. I prefer to reserve the term hormones to those messenger chemicals that are produced by the hormone glands of a human body and their synthetic counterparts (bioidentical hormones).

In 2004, the National Institutes of Health discontinued the Premarin-Provera arm of its Women’s Health Initiative study 1 year early, citing an increase in the risk of breast cancer, heart disease, blood clots, and stroke in women taking the study medications. This study did not use bioidentical estradiol, estriol, estrone, or progesterone. Instead, in the Premarin-Provera arm of the study women were given Premarin, a drug which contains non-bioidentical hormones that are derived from horse urine and Provera (medroxyprogesterone).

There is no evidence that the use of bioidentical hormones increases the risk of developing cancer when the dosage schedule follows the pattern that we see in healthy, young individuals.

There is no question that a mother’s breast milk and breastfeeding are best for an infant. However, there are some contraindications to breastfeeding. They include certain health conditions of the mother and certain medications that the mother is using that may be transmitted to the infant by breast milk. In addition, alternatives to breastfeeding are necessary when when mothers are not able to produce enough milk or when they choose not to breastfeed because of limited maternity leave or the need to work outside of the home.

Here are some links with information about the dangers of conventional infant formula. There are also links with information about healthy alternatives that are vital for parents who have young children. It is important that parents recognize that infant formula is junk food for the youngest and most vulnerable members of our society. We have a choice and options to feed our children properly and the responsibility to set a sound foundation for future growth and development.

It is my hope that all parents who are now giving their infants store bought formula give this information serious consideration. If you are already making homemade baby formula or have done so in the past, please share your experiences by responding to this post.

Healthy Alternative to Conventional Infant Formula
The Deadly Influence of Formula in America
Soy Baby Formula Linked to Behavioral Problems
Breastfeeding Ads Challenged by Formula Companies
FAQs on Homemade Baby Formula – Weston Price Foundation
Infant formula warning: The poisoning of infants with formula products, and why breastfeeding is best
FDA Claims Cancer-Causing Chemical in Infant Formula is “Safe”
Infant Formula Cans Lined with Toxic Chemical BPA

In a recent newsgroup message somebody posted a list of estrogen side effects (see below) in response to a research study which concluded that estradiol appears to be a useful treatment for women with schizophrenia.

Here is my response to that post.


This list of “side effects” of “estrogen” is misleading.

First of all, the term “estrogen” is very imprecise.

The three main endogenously produced estrogens which are also available as bioidentical formulations for hormone replacement therapy are estradiol, estriol, and estrone.

In the mainstream media and even in some of the scientific literature the term estrogens is used very loosely. It is often not clear to the layperson or health professional if it is used to reference endogenously produced estrogens, bioidentical replacement hormones, or nonbioidentical patent drugs like Premarin or ethinyl estradiol which are foreign to the body.

Many of the “side effects” listed below are unique to these nonbioidentical patent drugs which have very little in common with endogenously produced estradiol, estrone, and estriol.

When patients experience symptoms of hormonal imbalance it is important to consider the following elements:

1) The hormone levels could be too high – This is rare in the case of estradiol, except when patients are using supraphysiological doses of replacement hormones.
2) The hormone levels could be too low – This is most common in perimenopausal and postmenopausal women but is unfortunately more commonly seen in younger women of childbearing age as well.
3) The number of hormone receptors may have declined. Receptors are essential to hormonal functioning because it is only when a hormone connects with a receptor that a signal is transmitted to the cell.
4) Loss of rhythmicity – All hormones have unique rhythms that when disrupted can explain many symptoms that women experience when their hormones are out of balance.

Except for those “side effects” that are unique to nonbioidentical patent drugs, all other symptoms can be expected to improve if the bioidentical hormone replacement therapy is used to reestablish the optimal hormone levels AND the rhythm that we see in healthy young women.

“[Talking] to your doctor about the risks of taking estrogen” is usually an exercise in futility because most doctors (even endocrinologists and gynecologists) don’t know how to evaluate and treat hormone imbalances. This lack of knowledge and experience leaves women either hormonally depleted or with inadequate hormone replacement therapy using statically dosed bioidentical hormones or inherently dangerous patent drugs.

Here is a good resource for those who want to learn more about rhythmically dosed bioidentical hormone replacement:

www.thewileyprotocol.com

Fred Bloem, M.D.


Sent: Tuesday, August 19, 2008 8:00 PM
Subject: Re: [IntPsy] Estrogen as a treatment for schizophrenia in women

Estrogen may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

breast pain or tenderness
upset stomach
vomiting
heartburn
constipation
diarrhea
gas
weight gain or loss
leg cramps
nervousness
depression
dizziness
burning or tingling in the arms or legs
tight muscles
hair loss
unwanted hair growth
spotty darkening of the skin on the face
difficulty wearing contact lenses
swelling, redness, burning, itching, or irritation of the vagina
vaginal discharge
change in sexual desire
cold symptoms
Some side effects can be serious. If you experience any of these symptoms or those listed in the IMPORTANT WARNING section, call your doctor immediately:

bulging eyes
sore throat, fever, chills, cough, and other signs of infection
pain, swelling, or tenderness in the stomach
loss of appetite
weakness
yellowing of the skin or eyes
joint pain
movements that are difficult to control
rash or blisters
hives
itching
swelling of the eyes, face, tongue, throat, hands, arms, feet, ankles, or lower legs
hoarseness
difficulty breathing or swallowing
Estrogen may increase your risk of developing cancer of the ovaries or gallbladder disease that may need to be treated with surgery. Talk to your doctor about the risks of taking estrogen.


On Tue, Aug 19, 2008 at 2:22 PM, Dan Stradford wrote:

http://www.ncbi.nlm.nih.gov/pubmed/18678800
Estrogen in severe mental illness: a potential new treatment approach.
Kulkarni J, de Castella A, Fitzgerald PB, Gurvich CT, Bailey M, Bartholomeusz C, Burger H.
Alfred Psychiatry Research Centre, The Alfred and Monash University, School of Psychology, Psychiatry, and Psychological Medicine, The Alfred Hospital, Melbourne, Victoria 3004, Australia. j.kukarni@alfred.org.au

CONTEXT: Accumulating evidence suggests that estrogens may have therapeutic effects in severe mental illnesses, including schizophrenia, via neuromodulatory and neuroprotective activity. OBJECTIVE: To compare the efficacy of adjunctive transdermal estradiol with that of adjunctive placebo in the treatment of acute psychotic symptoms. DESIGN: Randomized, double-blind study. SETTING: Patients were recruited from inpatient acute hospital wards and outpatient clinics of 2 metropolitan Melbourne general hospitals. PARTICIPANTS: One hundred two women of childbearing age with schizophrenia. All participants were in an acute or chronic phase of their illness; 73 participants were outpatients and the rest were inpatients. Intervention Patients were randomized to receive 100 microg of transdermal estradiol (n = 56) or transdermal placebo (n = 46) for 28 days. MAIN OUTCOME MEASURES: Psychopathological symptoms were assessed weekly with the Positive and Negative Syndrome Scale. RESULTS: The addition of 100 microg of transdermal estradiol significantly reduced positive (P < .05) and general psychopathological (P < .05) symptoms during the 28-day trial period compared with women receiving antipsychotic medication alone. CONCLUSION: Estradiol appears to be a useful treatment for women with schizophrenia and may provide a new adjunctive therapeutic option for severe mental illness. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00206570.